Pathalys Pharma
Raleigh, United States · $255.0M raised
- Headquarters
- Raleigh, North Carolina
- Business Model
- B2B
- Website
- pathalys.com
- Total Funding
- $255.0M
- Last Round
- $105.0M Series BAug 2024
- Rounds
- 2
About
Late-stage clinical biopharmaceutical company developing enhanced therapeutics to improve patient management of chronic diseases.
Summary
Pathalys Pharma is a Biotech company based in Raleigh, United States. It has raised $255.0M in total across 2 rounds, most recently a $105.0M Series B round in Aug 2024. Investors include Abingworth, OrbiMed and J.P. Morgan Life Sciences Private Capital.
Tech & App Stack
1 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Aug 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Google-backed biotechnology company focused on understanding the biology of aging to develop inte...